Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: A pilot study

BJU International

Volumn 103, Issue 5, 2009, Pages 626-629

  Kotsar, Andres ^a   Isotalo, Taina ^c   Juuti, Hanne ^b   Mikkonen, Joonas ^b   Leppiniemi, Jenni ^b   Hänninen, Venla ^b   Kellomäki, Minna ^b   Talja, Martti ^c   Tammela, Teuvo L J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

5 reductase inhibitors; Bioabsorbable; Prostatic stents; Urinary retention

Indexed keywords

DUTASTERIDE; POLYGLACTIN;

ADULT; AGED; ARTICLE; BIODEGRADABILITY; CLINICAL ARTICLE; COMORBIDITY; DEVICE; FOLLOW UP; HUMAN; INDWELLING CATHETER; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; URETER STENT; URINE RETENTION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; AZASTEROIDS; BIOCOMPATIBLE MATERIALS; ENZYME INHIBITORS; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; PILOT PROJECTS; POLYGLYCOLIC ACID; PROSTATIC HYPERPLASIA; STENTS; TREATMENT OUTCOME; URETHRA; URINARY RETENTION;

EID: 60449097597     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08111.x     Document Type: Article

References (11)

1. Miller J, Tarter TH. Update on the use of dutasteride in the management of benign prostatic hypertrophy. Clin Interv Aging 2007 2 : 99 104
2. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, the Writing Committee. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989 141 : 243 7
3. Pickard R, Emberton M, Neal DE et al. The management of men with acute urinary retention. Br J Urol 1998 81 : 712 20
4. Yachia D, Beyar M, Aridogan I. A new, large calibre, self-retaining temporary intraprostatic stent (ProstaCoil) in the treatment of prostatic obstruction. Br J Urol 1994 74 : 47 9
5. Yachia D, Aridogan IA. The use of a removable stent in patients with prostate cancer and obstruction. J Urol 1996 155 : 1956 8
6. Isotalo T, Talja M, Välimaa T, Törmälä P, Tammela TLJ. A pilot study of a bioabsorbable self-reinforced poly l-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement. BJU Int 2000 85 : 83 6
7. Isotalo T, Talja M, Hellström P et al. A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from benign prostatic hyperplasia. BJU Int 2001 88 : 30 4
8. Vaajanen A, Nuutinen JP, Isotalo T, Törmälä P, Tammela TLJ, Talja M. Expansion and fixation properties of a new braided biodegradable urethral stent. An experimental study in the rabbit. J Urol 2003 169 : 1171 4
9. Isotalo T, Nuutinen JP, Vaajanen A et al. Biocompatibility properties of a new braided biodegradable urethral stent: a comparison with a biodegradable spiral and braided metallic stent in the rabbit urethra. BJU Int 2006 97 : 856 9
10. Issa MM, Runken MC, Grogg AL, Shah MB. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride. Am J Med Care 2007 13 : S10 6
11. Marihart S, Harik M, Djavan B. Dutasteride: a review of current data on a novel dual inhibitor of 5α reductase. Rev Urol 2005 7 : 203 10